presymptomatic testing

presymptomatic testing

Molecular medicine The early testing of a Pt who may have–based on family Hx–a genetic disorder–eg, Huntington's disease or adult polycytic kidney disease, that manifests itself late in life. Cf Genotype.
Mentioned in ?
References in periodicals archive ?
This study will enable to know the reasons why subjects at-risk for Familial Amyloid Polyneuropathy (FAP), Huntington's Disease (HD), and Machado-Joseph Disease (MJD) want to perform the PST and compare the results with the motivations of the subjects atrisk for Hereditary Hemochromatosis (HH) which also wish to carry the presymptomatic testing (PST).
The facile PCR-based assay that we have described could be used to confirm the diagnosis of BHD, or for presymptomatic testing of members of the extended BHD family.
There are two types of predictive genetic testing- Presymptomatic Testing & Susceptibility Testing.
This may present a better alternative to using CGG sizing as a first-line test in newborns or very young children, because detection of PM alleles that have been associated with late-onset disorders (30, 31) would raise the ethical issue of presymptomatic testing for currently untreatable and nonpreventable disorders with incomplete penetrance (32).
Presymptomatic testing for adult-onset diseases in patients who have not yet reached the age of legal majority is generally not recommended because of the psychologic burden on the patient and may be prohibited by state or local laws.
1994, Timman, Maat-Kievit, Roos, & Tibben, 2004) have studied the psychological consequences of presymptomatic testing.
Presymptomatic testing of children (not recommended for individuals <18 years)
One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: Emotional impact of the test outcome and decisions on risk management (surveillance and prophylactic mastectomy).
presymptomatic testing for predicting adult-onset disorders such as Huntington's disease;
Early Warning: Cases and Ethical Guidance for Presymptomatic Testing in Genetic Diseases.
They increase our ability to diagnose individuals with an apparent genetic condition by means of diagnostic and confirmatory testing, to predict disease for individuals with presymptomatic testing, to identify carrier status in potential parents, and to ascertain the genetic status of an unborn child with prenatal testing.